IRIS
BIANCHI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 79.807
EU - Europa 6.032
AS - Asia 1.744
SA - Sud America 62
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 31
AF - Africa 12
Totale 87.722
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 79.725
IT - Italia 1.425
IE - Irlanda 1.138
CN - Cina 1.132
UA - Ucraina 791
DE - Germania 696
FR - Francia 494
SE - Svezia 406
GB - Regno Unito 362
KR - Corea 237
FI - Finlandia 202
PL - Polonia 183
RU - Federazione Russa 118
IN - India 81
CA - Canada 68
BE - Belgio 58
JP - Giappone 48
UZ - Uzbekistan 43
BR - Brasile 36
NL - Olanda 34
AU - Australia 31
ES - Italia 27
EU - Europa 25
KG - Kirghizistan 25
HK - Hong Kong 22
IL - Israele 20
RO - Romania 19
SG - Singapore 19
TR - Turchia 17
CH - Svizzera 15
MY - Malesia 15
VN - Vietnam 15
AE - Emirati Arabi Uniti 14
SK - Slovacchia (Repubblica Slovacca) 13
MX - Messico 12
ID - Indonesia 11
PE - Perù 9
AT - Austria 8
EG - Egitto 8
HU - Ungheria 8
IR - Iran 8
PH - Filippine 7
PK - Pakistan 7
CL - Cile 6
GR - Grecia 6
TH - Thailandia 6
TW - Taiwan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
DK - Danimarca 5
RS - Serbia 5
AR - Argentina 4
BD - Bangladesh 3
CO - Colombia 3
LT - Lituania 3
LV - Lettonia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
BG - Bulgaria 2
BO - Bolivia 2
HR - Croazia 2
IQ - Iraq 2
PA - Panama 2
SC - Seychelles 2
A1 - Anonimo 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EE - Estonia 1
LB - Libano 1
LK - Sri Lanka 1
MA - Marocco 1
MN - Mongolia 1
SA - Arabia Saudita 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 87.722
Salva come PNG Salva come JPEG
Città #
Wilmington 23.354
Houston 22.128
Woodbridge 17.472
Fairfield 3.307
Chandler 1.896
Ashburn 1.575
Seattle 1.345
Ann Arbor 1.310
Cambridge 1.217
Dublin 1.034
Medford 747
Jacksonville 635
Dearborn 573
Beijing 429
Rome 378
Lawrence 354
New York 318
Zhengzhou 256
San Diego 225
Menlo Park 207
Kraków 162
Redwood City 111
Milan 81
Seoul 76
Mülheim 74
Shanghai 72
London 70
Cedarhurst 68
Norwalk 63
Brussels 54
Helsinki 51
Hefei 49
Nanjing 49
Boardman 42
Falls Church 40
San Mateo 40
Toronto 36
Engelhard 34
Guangzhou 34
Esslingen am Neckar 31
Mountain View 31
Nanchang 31
Verona 30
Redmond 28
Kunming 27
Jinan 26
University Park 25
Detroit 24
Palo Alto 23
Atlanta 22
Kilburn 21
Manitou Springs 21
Los Angeles 20
Saint Petersburg 20
Auburn Hills 19
Council Bluffs 19
Perugia 19
Del Norte 18
Florence 17
Paris 17
Pune 16
Trieste 16
Wuhan 16
Chicago 15
San Jose 14
Bari 13
Hangzhou 13
Phoenix 13
Torino 13
Dubai 12
Naples 12
Chengdu 11
Hounslow 11
Ottawa 11
Salt Lake City 11
Shenyang 11
Sydney 11
Tokyo 11
Amsterdam 10
Dong Ket 10
Genova 10
Napoli 10
Nuremberg 10
Palermo 10
Creede 9
Fuzhou 9
Genazzano 9
Hong Kong 9
Lima 9
Messina 9
Dallas 8
Frankfurt am Main 8
Hebei 8
Madrid 8
Pisa 8
San Francisco 8
St. George 8
Catania 7
Center 7
Islington 7
Totale 80.876
Salva come PNG Salva come JPEG
Nome #
Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data 1.590
Crusted scabies in a liver transplant patient mimicking rupioid psoriasis 1.350
Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study 1.161
Power Doppler ultrasound assessment of vascularization in hidradenitis suppurativa lesions 721
The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursors 704
Loss of CRABP-II Characterizes Human Skin Poorly Differentiated Squamous Cell Carcinomas and Favors DMBA/TPA-Induced Carcinogenesis 642
Dermoscopic monitoring of efficacy of Ingenol mebutate in the treatment of pigmented and non-pigmented basal cell carcinomas 569
Is weekly dose of adalimumab a simple approach for resistant psoriasis? 509
Efficacy and safety of infliximab in psoriatic patients over the age of 65 487
Leflunomide-induced DRESS syndrome 473
AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa 461
Alopecia areata e trachionichia associato a sindrome da insufficienza endocrina plurighiandolare. 455
Infliximab biosimilar CT-P13 in the treatment of chronic plaque psoriasis. Data from the Psobiosimilars registry. 439
Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis. 431
Angiosarcoma cutaneo epitelioide 426
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients 422
Treatment of trachyonychia with tazarotene 421
Alexithymia and Plaque Psoriasis: Preliminary Investigation in a Clinical Sample of 250 Patients. 418
Successful treatment of multiple filiform facial warts with imiquimod 5% cream in a patient infected by human immunodeficiency virus 417
Treatment of kerion with fluconazole [30] 415
Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial 415
Psodisk, a new visual method for assessing the burden of psoriasis on patients 414
Tazarotene 0-1% gel for psoriasis of the fingernails and toenails: an open, prospective study [9] 411
Cheratodermia puntata porocheratosica 411
Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B [10] 408
Apremilast for the treatment of psoriasis. 405
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 404
Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis 403
Actinic keratosis treated with an immune response modifier: a case report of six patients 402
Experimental T cells immunotherapy by tumor-loaded ECP-generated dendritic antigen presenting cells 402
Tazarotene as alternative topical treatment for onychomycosis 401
Pachydermodactyly: a case of an unusual type of reactive digital fibromatosis 397
Alopecia areata e trachionichia associato a sindrome da insufficienza indocrina plurighiandolare 393
Bullous pemphigoid and severe erythrodermic psoriasis: combined low-dose treatment with cyclosporine and systemic steroids 391
Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports 391
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 388
Severe erytrodermic psoriasis and arthritis as clinical presentation of a CARD14-mediated psoriasis (CAMPS) 388
Pachydermoperiostosis: Study of epidermal growth factor and steroid receptors 387
Pharmacokinetic drug evaluation of brodalumab for the treatment of psoriasis 383
Remission and time of resolution of nail psoriasis during infliximab therapy [27] 381
Chronic mucocutaneous candidiasis and alopecia areata as cutaneous expressions of autoimmune polyglandular syndrome type I 381
Agminated Dermal Melanocytosis in the Territory of Ota's Nevus 381
Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management 381
Severe acne successfully treated with etanercept 378
Topical lactoferrin can improve stable psoriatic plaque 378
Hypodermal Adipose Tissue Sonoelastography for Monitoring Treatment Response in Patients with Plaque Psoriasis 378
Bullous dermatomyositis: A marker of poor prognosis and aggressive internal malignancy? 376
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 374
Type I lamellar ichthyosis improved by tazarotene 0.1% gel 374
Myxoid dermatofibrosarcoma protuberans: morphological, ultrastructural and immunohistochemical features 373
Oral lichen planus: Novel acquisitions in the pathogenesis and treatment 373
Local treatment of chronic cutaneous leg ulcers with recombinant human granulocyte-macrophage colony-stimulating factor. 371
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study. 370
Antifungal activity of Cardiospermum halicacabum L. (Sapindaceae) against Trichophyton rubrum occurs through molecular interaction with fungal Hsp90 370
Stress reactivity in psoriatic patients 369
Cutaneous features of myotonic dystrophy types 1 and 2: implication of premature aging and vitamin d homeostasis 369
Clinical and confocal evaluation of avenanthramides-based daily cleansing and emollient cream in pediatric population affected by atopic dermatitis and xerosis 369
Phrynoderma: a cutaneous sign of an inadequate diet 365
Tildrakizumab for treating psoriasis 365
Bowenoid papulosis and invasive Bowen's disease: a multidisciplinary approach 362
Morbid obesity and psoriasis: Disease remission after laparoscopic sleeve gastrectomy 361
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases 360
Brodalumab for the treatment of psoriasis 360
Pharmacokinetic drug evaluation of dalbavancin for the treatment of skin infections 360
Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts 354
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody 353
What happened after the clinical trials: Long-term safety and efficacy of ustekinumab in daily clinical practice 353
Role of HLA- C*06 in clinical response to ustekinumab: evidence from real-life in a large cohort of European patients. 353
Allergic contact dermatitis of the lip margins from para-tertiary-butylphenol in a lip liner 352
Confocal reflectance microscopy in pityriasis rubra pilaris 352
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 351
Psoriasiform sarcoidosis: an unusual variety 351
Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness 350
High-dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: Efficacy, safety and impact on patients' quality of life 350
Mixoma intramuscolare del volto 350
Melanoma-associated markers expression in blood: MUC-18 is associated with advanced stages in melanoma patients 346
Zosteriform metastasis of occult bronchogenic carcinoma 346
The first skin cancer screening day at the Italian parliament: A Euromelanoma initiative 346
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey 346
Psodisk, a new visual method for assessing the burden of psoriasis on patients 345
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis 344
Effect of anti IL-12/23 on body composition: results of bioelectrical impedance analysis in Caucasian psoriatic patients 344
Abnormal bcl-2 and 'tissue' transglutaminase expression in psoriatic skin 343
Tofacitinib for the treatment of psoriasis 343
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 343
Quality-of-life impairment in hidradenitis suppurativa 342
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation 341
A 2-year history of an asymptomatic scalp nodule - Cutaneous metastasis from renal cell carcinoma. 340
TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis 340
Tuberous sclerosis with specific renal involvement 339
The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the Literature 338
Familial occurrence of pseudoxanthoma-elasticum-like papillary dermal elastolysis 337
Elementi di dermatologia 337
Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis 336
Pachyonychia congenita with late onset of nail dystrophy: a new clinical entity? 336
Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma 336
The efficacy and tolerability of 5-aminolevulinic acid 5% thermosetting gel photodynamic therapy (PDT) in the treatment of mild-to-moderate acne vulgaris. A two-center, prospective assessor-blinded, proof-of-concept study 335
Disseminated pagetoid reticulosis presenting as cytotoxic CD4/CD8 double negative cutaneous T-cell lymphoma 334
Influence and variation of the body mass index in patients treated with etancercept for psoriasis 334
Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146 334
Totale 41.758
Salva come PNG Salva come JPEG
Categoria #
all - tutte 190.477
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 190.477
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.322 0 0 0 0 0 0 0 0 0 0 0 2.322
2019/202024.987 1.932 1.842 1.491 2.203 2.364 2.586 2.300 2.274 2.451 2.145 1.666 1.733
2020/202117.910 1.751 1.818 1.760 2.130 2.426 2.162 2.163 1.884 399 635 503 279
2021/20224.016 205 441 264 180 182 313 315 191 267 320 292 1.046
2022/20235.167 496 613 199 619 468 1.135 429 288 474 77 237 132
2023/20241.906 251 69 140 72 185 425 228 183 53 192 108 0
Totale 89.989